Accessibility Menu

Disc Medicine

(NASDAQ) IRON

Current Price$79.75
Market Cap$3.05BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2022)+301%
5 Year+40%
1 Year+49%
1 Month+19%

Disc Medicine Financials at a Glance

Market Cap

$3.05BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$241.60M

EPS (TTM)

-$6.62

P/E Ratio

-12.05

Dividend

$0.00

Beta (Volatility)

0.92 (Low)

Price

$79.75

Volume

464

Open

$78.10

Previous Close

$79.76

Daily Range

$77.31 - $82.50

52-Week Range

$40.00 - $99.50

Estimated Earnings Date

Aug 6, 2026

About Disc Medicine

Industry

Biotechnology

Employees

154

CEO

John D. Quisel, PhD

Headquarters

Watertown, MA 02472, US

IRON Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-36.95%

Return on Capital

-31.82%

Return on Assets

-32.20%

Earnings Yield

-8.30%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.05BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

38.20M

Volume

464

Avg. Volume

563.22K

Financials (TTM)

Gross Profit

-$176.00K

Operating Income

-$265.60M

EBITDA

-$238.25M

Operating Cash Flow

-$201.25M

Capital Expenditure

-$82.00K

Free Cash Flow

-$201.34M

Cash & ST Invst.

$730.16M

Total Debt

$31.06M

Disc Medicine Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$89.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$3.05BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$32.41M

N/A

Employees

94

N/A

Net Income

-$63.50M

-86.3%

EBITDA

-$63.36M

-91.7%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$730.16M

+5.1%

Total Debt

$31.06M

+1.4%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$30.64M

+1.6%

Short Term Debt

$419.00K

-12.5%

Return on Assets

-32.20%

N/A

Return on Invested Capital

-36.94%

N/A

Free Cash Flow

-$62.24M

-47.4%

Operating Cash Flow

-$62.24M

-50.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TARSTarsus Pharmaceuticals, Inc.
$70.55+5.22%
ADPTAdaptive Biotechnologies Corporation
$20.82-3.16%
ZLABZai Lab Limited
$19.35+1.42%
AAPGAscentage Pharma Group International
$18.68-3.56%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$72.23-0.05%
RIVNRivian Automotive
$16.49-0.18%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$40.38+0.05%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.84-0.08%

Questions About IRON

What is the current price of Disc Medicine?

Disc Medicine is trading at $79.76 per share.

What is the 52-week range for Disc Medicine?

Over the past 52 weeks, Disc Medicine has traded between $40.00 and $99.50.

How much debt does Disc Medicine have?

As of the most recent reporting period, Disc Medicine reported total debt of $31.06M.

How much cash does Disc Medicine have on hand?

Disc Medicine reported $88.91M in cash and cash equivalents in its most recent financial results.

What is Disc Medicine’s dividend yield?

Disc Medicine does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.